Abstract:Background Recently, increasing evidence has indicated that platelet-activating factor acetylhydrolase 1b catalytic subunit 3 (PAFAH1B3) plays an important role in several cancers. However, its role in lung adenocarcinoma (LUAD) has not been reported until now. Methods The expression of PAFAH1B3 in LUAD was determined by using the Gene Expression Profiling Interactive Analysis (GEPIA) database and real-time PCR (RT–PCR), western blot and immunohistochemical (IHC) analyses. A chi-square test was used to investigate the correlation between PAFAH1B3 expression and clinical parameters. Cox regression and Kaplan–Meier analysis were performed to analyze the prognostic value of PAFAH1B3. The CCK-8 assay, clone formation assay, transwell invasion assay and flow cytometry were conducted to detect cell proliferation, clone formation, invasion and the cell cycle. The xenograft tumor model was constructed to explore the function of PAFAH1B3 in vivo . Western blot and IHC analyses were performed to detect epithelial-to-mesenchymal transition (EMT)-related markers. Immune Cell Abundance Identifier (ImmuneCellAI) and IHC analyses were used to analyze the effect of PAFAH1B3 on immune cell infiltration. Results Our study showed that the expression of PAFAH1B3 was upregulated in LUAD tissues and cells compared with noncancerous tissues and cells. Additionally, the results indicated that the expression of PAFAH1B3 was positively correlated with distant metastasis, TNM stage and poor clinical outcome and it was an independent prognostic risk factor for LUAD. In addition, silencing PAFAH1B3 suppressed cell proliferation, colony formation, and invasion and increased the cell population in the G0-G1 phases in vitro . Furthermore, our results showed that knockdown of PAFAH1B3 increased the epithelial marker E-cadherin level and decreased the mesenchymal marker N-cadherin level in vitro and in vivo . We also proved that PAFAH1B3 downregulation inhibited tumorigenesis and neutrophil infiltration in the xenograft tumor model. Conclusion Our studies indicate that PAFAH1B3, a prognostic risk factor, promotes proliferation, invasion and EMT and affects immune infiltrates in LUAD.

PLAGL1 is Associated with Prognosis and Cell Proliferation in Pancreatic Adenocarcinoma

PLAGL2 increases adriamycin resistance and EMT in breast cancer cells by activating the Wnt pathway

Opposing Functions of PLAG1 in Pleomorphic Adenoma: a Microarray Analysis of PLAG1 Transgenic Mice.

Overexpression Of Pleomorphic Adenoma Gene-Like 2 Is A Novel Poor Prognostic Marker Of Prostate Cancer

Pleomorphic Adenoma Gene 1 Mediates the Role of Karyopherin Alpha 2 and Has Prognostic Significance in Hepatocellular Carcinoma

Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma Via Regulating the Cell Cycle

PLAG1 Expression and Its Relationship with ER and P53 in Pleomorphic Adenoma

Placenta-specific Protein 1 Promotes Cell Proliferation and Invasion in Non-Small Cell Lung Cancer.

GLUT1 Regulates the Tumor Immune Microenvironment and Promotes Tumor Metastasis in Pancreatic Adenocarcinoma via ncRNA-mediated Network

PLS3 predicts poor prognosis in pancreatic cancer and promotes cancer cell proliferation via PI3K/AKT signaling

Paip1 Predicts Poor Prognosis and Promotes Tumor Progression Through AKT/GSK-3β Pathway in Lung Adenocarcinoma.

KLK10/LIPH/PARD6B/SLC52A3 Are Promising Molecular Biomarkers for the Prognosis of Pancreatic Cancer Through a Cerna Network

PLK1 is a Potential Prognostic Factor Associated with the Tumor Microenvironment in Lung Adenocarcinoma

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma

Upregulation of PAIP1 promotes the gallbladder tumorigenesis through regulating PLK1 level

Phospholipid Phosphatase 4 as a Driver of Malignant Glioma and Pancreatic Adenocarcinoma

PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma

Simultaneous high expression of PLD1 and Sp1 predicts a poor prognosis for pancreatic ductal adenocarcinoma patients.

PPA1 Promotes Breast Cancer Proliferation and Metastasis Through PI3K/AKT/GSK3β Signaling Pathway

High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma

WITHDRAWN: PLK1 is A Promising Biomarker for the Prognosis of Lung Adenocarcinoma